Is Eovist Suitable for Arterial-Phase MR Imaging of Liver

Completed · Not applicable

Conditions studied: Liver Disease

In brief

To examine the quality of liver images produced when the contrast agent Eovist is used during MRI.

Key facts

Study ID
NCT02684526
Run by
University of Michigan
People needed
198
Starts
2011-12-01
Expected to finish
2016-10-01
Last updated by the study team
2016-12-16

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.